Clinical Trial Update: A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis/Bladder Pain Syndrome [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy trial update for LiRIS in females with interstitial cystitis/bladder pain syndrome completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Pain Syndrome
• Interstitial Cystitis

Drugs mentioned

• LiRIS

Snippet

Sponsor: Allergan | Conditions: Cystitis, Interstitial, Painful Bladder Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2018-01-04